Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024)
Roivant Sciences (ROIV) reported Goodwill & Intangibles of $136.0 million for Q2 2024, down 6.22% on a YoY basis from $145.0 million in Q3 2023, and down 1.33% quarter-over-quarter from $137.8 million in Q1 2024.
Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024) Analysis & Trends
Roivant Sciences has reported Goodwill & Intangibles for 3 years, with the latest figure at $136.0 million in Q2 2024.
- For the quarter ending Q2 2024, Goodwill & Intangibles fell 6.22% year-over-year to $136.0 million; the trailing twelve-month figure through Jun 2024 stood at $136.0 million (down 6.22% YoY), and the FY2024 full-year result was $137.8 million, down 4.86% from the prior year.
- Goodwill & Intangibles for Q2 2024 stood at $136.0 million, down from $137.8 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $166.5 million in Q4 2023, with the low at $136.0 million in Q2 2024.
- Historically, Goodwill & Intangibles has averaged $145.3 million across 3 years, with a median of $144.9 million in 2023.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles grew 9.89% — and 2024, when it decreased 6.22%.
- Roivant Sciences' Goodwill & Intangibles stood at $151.5 million in 2022, then advanced by 9.89% to $166.5 million in 2023, then retreated by 18.3% to $136.0 million in 2024.
- The last three Goodwill & Intangibles figures came in at $136.0 million (Q2 2024), $137.8 million (Q1 2024), and $166.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 136.01 Mn |
| Mar 31, 2024 | 137.84 Mn |
| Dec 31, 2023 | 166.47 Mn |
| Sep 30, 2023 | 140.62 Mn |
| Jun 30, 2023 | 145.04 Mn |
| Mar 31, 2023 | 144.88 Mn |
| Dec 31, 2022 | 151.49 Mn |
| Sep 30, 2022 | 140.30 Mn |
| Jun 30, 2022 | 145.43 Mn |